NCT06197789View on ClinicalTrials.gov

Safety and Efficacy Study of TPX-105 for Correction of Nasojugal Groove

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

June 5, 2023

Study Completion Date

October 18, 2023

Conditions
Tear Trough Eyelid Deformity
Interventions
BIOLOGICAL

TPX-105

Subjects will be administered with autologous fibroblasts through injection

BIOLOGICAL

Placebo

Subjects will be administered with Placebo through injection

Trial Locations (4)

14584

Soonchunhyang University Hospital Bucheon, Bucheon-si

41944

Kyungpook National University Hospital, Daegu

06591

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Tego Science, Inc.

INDUSTRY

NCT06197789 - Safety and Efficacy Study of TPX-105 for Correction of Nasojugal Groove | Biotech Hunter | Biotech Hunter